0001587221-15-000003.txt : 20150630 0001587221-15-000003.hdr.sgml : 20150630 20150630145203 ACCESSION NUMBER: 0001587221-15-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150630 DATE AS OF CHANGE: 20150630 EFFECTIVENESS DATE: 20150630 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Zosano Pharma Corp CENTRAL INDEX KEY: 0001587221 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 454488360 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-242801 FILM NUMBER: 15961152 BUSINESS ADDRESS: STREET 1: 34790 ARDENTECH COURT CITY: FREMONT STATE: CA ZIP: 94555 BUSINESS PHONE: 510-745-1200 MAIL ADDRESS: STREET 1: 34790 ARDENTECH COURT CITY: FREMONT STATE: CA ZIP: 94555 FORMER COMPANY: FORMER CONFORMED NAME: ZP Holdings Inc DATE OF NAME CHANGE: 20130919 D 1 primary_doc.xml X0707 D LIVE 0001587221 Zosano Pharma Corp 34790 ARDENTECH COURT FREMONT CA CALIFORNIA 94555 510-745-1200 DELAWARE ZP Holdings Inc Corporation true 2012 Vikram Lamba c/o Zosano Pharma Corporation 34790 Ardentech Court Fremont CA CALIFORNIA 94555 Executive Officer Director Peter Daddona c/o Zosano Pharma Corporation 34790 Ardentech Court Fremont CA CALIFORNIA 94555 Executive Officer Director M. James Barrett c/o Zosano Pharma Corporation 34790 Ardentech Court Fremont CA CALIFORNIA 94555 Director Troy Wilson c/o Zosano Pharma Corporation 34790 Ardentech Court Fremont CA CALIFORNIA 94555 Director Bruce Steel c/o Zosano Pharma Corporation 34790 Ardentech Court Fremont CA CALIFORNIA 94555 Director Kleanthis Xanthopoulos c/o Zosano Pharma Corporation 34790 Ardentech Court Fremont CA CALIFORNIA 94555 Director Joseph Hagan c/o Zosano Pharma Corporation 34790 Ardentech Court Fremont CA CALIFORNIA 94555 Director Winnie Tso c/o Zosano Pharma Corporation 34790 Ardentech Court Fremont CA CALIFORNIA 94555 Executive Officer Laxmi Peri c/o Zosano Pharma Corporation 34790 Ardentech Court Fremont CA CALIFORNIA 94555 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2015-06-23 false true true true false 0 300000 0 300000 Total offering amount represents the maximum cash consideration that may be received by the issuer upon exercise of the warrant to which this notice relates. The warrant was issued in partial consideration for a term loan made by a third party. false 1 0 0 0 None, other than compensation in the ordinary course of business. false Zosano Pharma Corp Vikram Lamba Vikram Lamba Chief Executive Officer 2015-06-30